section name header

Information

Synonym/Acronym

IgA, IgD, IgG, and IgM.

Rationale

To quantitate immunoglobulins A, D, G, and M as indicators of immune system function, to assist in the diagnosis of conditions that result in deficient or excessive production of immunoglobulins; to investigate immune system disorders such as multiple myeloma. To assess IgE levels in order to identify the presence of an allergic or inflammatory immune response.

Patient Preparation

There are no food, fluid, activity, or medication restrictions unless by medical direction.

Normal Findings

Method: Nephelometry for IgA, IgD, IgG, and IgM. Immunoassay for IgE.

AgeConventional UnitsSI Units
IgA(Conventional Units × 0.01)
Newborn1–4 mg/dL0.01–0.04 g/L
1–9 mo2–80 mg/dL0.02–0.8 g/L
10–12 mo15–90 mg/dL0.15–0.9 g/L
2–3 yr18–150 mg/dL0.18–1.5 g/L
4–5 yr25–160 mg/dL0.25–1.6 g/L
6–8 yr35–200 mg/dL0.35–2 g/L
9–12 yr45–250 mg/dL0.45–2.5 g/L
Older than 12 yr40–350 mg/dL0.40–3.5 g/L
IgD(Conventional Units × 10)
NewbornGreater than 2 mg/dLGreater than 20 mg/L
AdultLess than 15 mg/dLLess than 150 mg/L
IgEConventional and SI Units
Less than 1 yrLess than 20 units/mL
2–4 yrLess than 85 units/mL
5–9 yrLess than 1500 units/mL
10 yr and olderLess than 160 units/mL
IgG(Conventional Units × 0.01)
Newborn650–1,600 mg/dL6.5–16 g/L
1–9 mo250–900 mg/dL2.5–9 g/L
10–12 mo290–1,070 mg/dL2.9–10.7 g/L
2–3 yr420–1,200 mg/dL4.2–12 g/L
4–6 yr460–1,240 mg/dL4.6–12.4 g/L
Greater than 6 yr650–1,600 mg/dL6.5–16 g/L
IgM(Conventional Units × 0.01)
NewbornLess than 25 mg/dLLess than 0.25 g/L
1–9 mo20–125 mg/dL0.2–1.25 g/L
10–12 mo40–150 mg/dL0.4–1.5 g/L
2–8 yr45–200 mg/dL0.45–2 g/L
9–12 yr50–250 mg/dL0.5–2.5 g/L
Greater than 12 yr50–300 mg/dL0.5–3 g/L
Values vary by method and instrument.

Critical Findings and Potential Interventions

N/A

Overview

Study type: Blood collected in a gold-, red-, or red/gray-top tube; related body system: Circulatory/Hematopoietic, Immune, and Respiratory [IgE] systems.

Immunoglobulins A, D, E, G, and M are made by plasma cells in response to foreign substances. Immunoglobulins neutralize toxic substances, support phagocytosis, and destroy invading microorganisms. They are made up of heavy and light chains. Immunoglobulins produced by the abnormal proliferation of a single plasma cell (clone) are called monoclonal. Polyclonal increases result when multiple cell lines produce excessive amounts of antibody.

IgA is found mainly in secretions such as tears, saliva, and breast milk. It is believed to protect mucous membranes from viruses and bacteria.

The function of IgD is not well understood, but it is believed to interact directly with microorganisms and participate in the activation of B lymphocytes, mast cells, and monocytes.

IgG is the predominant serum immunoglobulin and is important in long-term defense against disease. It is the only antibody that significantly crosses the placenta.

IgM is the largest immunoglobulin, and it is the first antibody to react to an antigenic stimulus. IgM also forms natural antibodies, such as ABO blood group antibodies. The presence of IgM in cord blood is an indication of congenital infection.

IgE is an antibody whose primary response is to allergic reactions and parasitic infections. Most of the body’s IgE is bound to specialized tissue cells; little is available in the circulating blood. IgE binds to the membrane of special granulocytes called basophils in the circulating blood and mast cells in the tissues. Basophil and mast cell membranes have receptors for IgE. Mast cells are abundant in the skin and the tissues lining the respiratory and alimentary tracts. When IgE antibody becomes cross-linked with antigen/allergen, the release of histamine, heparin, and other chemicals from the granules in the cells is triggered. A sequence of events follows activation of IgE that affects smooth muscle contraction, vascular permeability, and inflammatory reactions. The inflammatory response allows proteins from the bloodstream to enter the tissues. Helminths (worm parasites) are especially susceptible to immunoglobulin-mediated cytotoxic chemicals. The inflammatory reaction proteins attract macrophages from the circulatory system and granulocytes, such as eosinophils, from circulation and bone marrow. Eosinophils also contain enzymes effective against the parasitic invaders. A nasal smear can be examined for the presence of eosinophils to screen for allergic conditions. Either a single smear or smears of nasal secretions from each side of the nose should be submitted, at room temperature, for Hansel staining and evaluation. Normal findings vary by laboratory, but generally, greater than 10% to 15% is considered eosinophilia or increased presence of eosonophils. Results may be invalid for patients already taking local or systemic corticosteroids.

Indications

IgA, IgD, IgG, and IgM

IgE

Interfering Factors

Factors That May Alter the Results of the Study

IgA, IgD, IgG, and IgM

  • Drugs and other substances that may increase immunoglobulin levels include asparaginase, cimetidine, and narcotics.
  • Drugs and other substances that may decrease immunoglobulin levels include dextran, oral contraceptives, methylprednisolone (high doses), and phenytoin.
  • Chemotherapy, immunosuppressive therapy, and radiation treatments decrease immunoglobulin levels.
  • Specimens with macroglobulins, cryoglobulins, or cold agglutinins tested at cold temperatures may give falsely low values.

IgE

  • Drugs and other substances that may cause a decrease in IgE levels include phenytoin and tryptophan.
  • Penicillin G has been associated with increased IgE levels in some patients with drug-induced acute interstitial nephritis.

Other Considerations

  • Normal IgE levels do not eliminate allergic disorders as a possible diagnosis.

Potential Medical Diagnosis: Clinical Significance of Results

Increased In

IgA

Polyclonal

IgD

Polyclonal (pathophysiology is unclear, but increases are associated with increases in IgM)

  • Chronic infections
  • Connective tissue disorders

    Monoclonal

  • IgD-type multiple myeloma (related to excessive production by a single clone of plasma cells)

IgE

Conditions involving allergic reactions or infections that stimulate production of IgE

IgG

Conditions that involve inflammation and/or development of an infection stimulate production of IgG.

Polyclonal

IgM

Polyclonal (humoral response to infections and inflammation; both acute and chronic)

Decreased In

IgA

IgD

IgE

  • Advanced cancer(related to generalized decrease in immune system response)
  • Agammaglobulinemia(related to decreased production)
  • Ataxia-telangiectasia (evidenced by familial immunodeficiency disorder)
  • IgE deficiency

IgG

IgM

  • Burns
  • Secondary IgM deficiency associated with IgG or IgA gammopathies

Nursing Implications, Nursing Process, Clinical Judgement

Before the Study: Planning and Implementation

Teaching the Patient What to Expect

  • Discuss how this test for IgA, IgD, IgG, and IgM can assess the immune system by evaluating the levels of immunoglobulins in the blood.
  • Inform the patient that testing for IgE can assist in identification of an allergic or inflammatory response.
  • Explain that a negative result does not necessarily preclude the presence of a sensitivity to an allergen.
  • Explain that a blood sample is needed for the test.

After the Study: Implementation & Evaluation Potential Nursing Actions

Treatment Considerations

  • Explain to patients with an IgA deficiency that care will be taken to request and provide blood products that have either been collected from IgA deficient donors or have been specially prepared to remove even small amounts of IgA (e.g., washed RBCs).
  • Explain that depending on the severity of the IgA deficiency, blood product infusion could initiate sensitization of the immune system or result in anaphylactic shock during a subsequent blood product transfusion, related to instigation by donor IgA in the product. IgA deficiency is a lifelong condition.

Nutritional Considerations

  • Increased IgE levels may be associated with allergy. Consideration should be given to consultation with a registered dietitian if the patient has food allergies.

Clinical Judgement

  • Consider how to explain the implications on lifestyle choices associated with positive study results.

Follow-Up and Desired Outcomes

  • Understands that additional testing may be necessary to evaluate or monitor disease progression and determine the need for a change in therapy.